Novartis Follows PhRMA in Seeking to Block Mississippi 340B Contract Pharmacy Law

Drugmaker Novartis has filed the second lawsuit challenging Mississippi's 340B contract pharmacy access law.
Drugmaker Novartis recently filed the second lawsuit that seeks to block implementation and enforcement of a recently enacted Mississippi law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BMS Requires Re-Designation of 340B Contract Pharmacies and New Requirements Intended to Prevent Alternative Distribution Models

Drug manufacturer BMS updated its 340B contract pharmacy restrictions to require pharmacies to re-register by June 21 and add additional requirements.
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, requiring registered sites to be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sobi Becomes 34th Drugmaker to Implement Contract Pharmacy Restrictions, Exelixis Tightens Contract Pharmacy Policy

Exelixis wordmark building-mounted sign
California-based Exelixis, a specialty manufacturer with two high-priced drug products on the market, announced it is further restricting contract pharmacy access to 340B hospitals in a May 31 letter published on 340B ESP. 
Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Expert Tip from The Alinea Group

img
img

TIP: Don’t assume your contract pricing is correct on every account just because it’s correct on one account.


Read More »

News Alert

In Key Hearing, GOP Lawmakers Raise Concerns About 340B Growth and Hospital Use While Democrats Urge Caution

Sue Veer, president and CEO, Carolina Health Centers, speaks at the House Energy and Commerce Committee's Oversight and Investigations Subcommittee hearing on June 4, 2024.
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Today’s 340B Congressional Hearing Will Include Multiple 340B Critics, Leading Hospital and Health Center Advocates

Dr. Anthony DiGiorgio, a free-market physician at UCSF who suggested last year that Congress could consider ending the 340B program, is one of four witnesses who will testify at a June 4 Congressional hearing on 340B.
A key House subcommittee oversight hearing today on the 340B program will include a witness who previously said Congress should [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Vertex is First to Offer Contract Pharmacy Policy Exemptions to Several States; GSK Restores Discounts To WV Providers

Drugmaker Vertex implemented 340B contract pharmacy restrictions but exempted the six states with laws prohibiting such policies.
Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Are You Prepared for an Office of Pharmacy Affairs (OPA) Audit?

SPONSORED CONTENT

All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions.  For the last five years, HRSA’s OPA has been completing approximately 200 audits a year and

Read More »

Two Drug Industry Lawsuits Challenge West Virginia’s 340B Contract Pharmacy Access Law

PhRMA and Novartis each challenged West Virginia's new 340B contract pharmacy access law in a federal district court.
An influential drug industry group and a major drugmaker each filed lawsuits challenging West Virginia’s 340B contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

UCB is 26th Drugmaker to Exempt Arkansas Providers from Contract Pharmacy Restrictions

UCB exterior sign and building
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions.
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live